
SBRA Stock Forecast & Price Target
SBRA Analyst Ratings
Bulls say
Sabra Health Care REIT is well-positioned for growth, with high projected internal growth driven by SHOP exposure in a market with rising demand and limited supply, and external growth opportunities at accretive pricing. The company's strong balance sheet and discounted FFO multiples also contribute to a positive outlook. However, rising costs and potential issues with operators could impact lease coverage ratios and performance, while the current pandemic may also have an adverse effect. The recent strategic transactions, loan repayment, and updated guidance bode well for the company's future performance and we reiterate our Market Outperform rating and raise our price target to $25.
Bears say
Sabra Health Care REIT is facing significant financial risks due to its high concentration in behavioral health facilities and its heavy reliance on non-profit tenants. Despite the recent repayment of a mortgage debt, the company's debt-to-EBITDA ratio remains high and its profitability may be negatively impacted by ongoing renegotiations with tenants and potential lease amendments. Additionally, the company's increased guidance for G&A expenses and FFO may suggest potential challenges in growing revenue and controlling expenses, causing concerns for long-term profitability.
This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.
SBRA Analyst Forecast & Price Prediction
Start investing in SBRA
Order type
Buy in
Order amount
Est. shares
0 shares